CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 55 filers reported holding CORVUS PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.90 and the average weighting 0.1%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 3,101,709 | $7,475,000 | 1.50% |
ADAMS STREET PARTNERS LLC | 3,275,616 | $7,894,000 | 1.20% |
Telemetry Investments, L.L.C. | 192,909 | $465,000 | 0.60% |
CHI Advisors LLC | 400,000 | $964,000 | 0.32% |
Orbimed Advisors | 6,943,654 | $16,734,000 | 0.22% |
Ikarian Capital, LLC | 482,610 | $1,163,000 | 0.17% |
Anson Funds Management LP | 528,358 | $1,273,000 | 0.12% |
BVF INC/IL | 1,370,947 | $3,304,000 | 0.12% |
VR Adviser, LLC | 250,000 | $603,000 | 0.08% |
PURA VIDA INVESTMENTS, LLC | 492,384 | $1,187,000 | 0.04% |